SCHEMBL3308263

SCHEMBL3308263

COC(=O)c1ccccc1Nc1c(Br)c(C)nn1-c1cc(F)ccc1F

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 5/20 0.44
ALDH1A1 P00352 4/20 0.41
HPGD P15428 2/20 0.41
CYP1A2 P05177 3/20 0.41
TSHR P16473 2/20 0.41
CYP2C19 P33261 2/20 0.41
CYP2D6 P10635 1/20 0.41
MAPT P10636 1/20 0.40
ALOX15 P16050 1/20 0.40
L3MBTL1 Q9Y468 3/20 0.39
KMT2A Q03164 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MAPK1 P28482 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
RIPK1 Q13546 1/20 0.38
MEN1 O00255 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1814785 0.92 ADORA1 (0.44) ADORA1ALDH1A1HPGDCYP1A2TSHR
SCHEMBL3299197 0.90 ADORA1 (0.48) ADORA1ALDH1A1HPGDCYP1A2TSHR
SCHEMBL1818960 0.85 KMT2A (0.42) ADORA1ALDH1A1HPGDCYP1A2CYP2C19
SCHEMBL1816999 0.83 ADORA1 (0.51) ADORA1ALDH1A1HPGDCYP1A2CYP2C19
SCHEMBL3306670 0.82 ADORA1 (0.46) ADORA1ALDH1A1HPGDCYP1A2CYP2C19
SCHEMBL1815545 0.82 KDM4E (0.41) ADORA1ALDH1A1HPGDCYP1A2CYP2C19
SCHEMBL1814345 0.81 TAS2R14 (0.43) ADORA1ALDH1A1HPGDCYP1A2CYP2C19
SCHEMBL1817098 0.81 TDP1 (0.52) ADORA1ALDH1A1HPGDCYP1A2TSHR
SCHEMBL1814489 0.81 ALDH1A1 (0.53) ALDH1A1HPGDCYP1A2TSHRCYP2C19
SCHEMBL3311807 0.79 ADORA1 (0.69) ADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100099681-A1 SUBSTITUTED 5-AMINOPYRAZOLES AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-04-22 US disclosed
US-20100099681-A1 SUBSTITUTED 5-AMINOPYRAZOLES AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-04-22 US disclosed
US-20100099681-A1 SUBSTITUTED 5-AMINOPYRAZOLES AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-04-22 US disclosed
WO-2010020363-A1 SUBSTITUTED 5-AMINOPYRAZOLES AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-02-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100099681-A1 SUBSTITUTED 5-AMINOPYRAZOLES AND USE THEREOF CYP3A5, ABAT, TPMT ADORA1 724/4885ALDH1A1 260/4885HPGD 194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.